NTAN1 and neoplasm: Surprisingly, the authors found that blockade of LTβR signaling in B16-OVA tumor bearing animals had no effect on PNAd expression on tumor vasculature and concurrent trafficking of naive OT-I cells into tumors was even enhanced, implicating no loss of HEV function.